Dr. Ivana Gojo, MD

Dr. Gojo practices at Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland.

Dr. Gojo's NPI, 1194765677, was assigned on June 7, 2006. Dr. Gojo holds Maryland license D57450.

Dr. Gojo's primary practice is Johns Hopkins Hospital Nelson/Harvey Building, at 600 N Wolfe St, Baltimore, MD 21287 in Baltimore City. The practice phone is (855) 662-3017.

Dr. Gojo's primary practice is Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland. Dr. Gojo is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Gojo to 1 more home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gojo practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Gojo's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Gojo is licensed in Maryland.

CMS data shows 606 Medicare services from Dr. Gojo across 8 procedure codes in 2024, for 130 Medicare patients. Medicare paid $49,369 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 130 Medicare patients who saw Dr. Gojo in 2024. The largest group is 65 to 74, with 73 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gojo's median patient age at 72, with 40% women.

In 2024, Dr. Gojo wrote 303 Medicare Part D claims for 32 patients. 79% of them were for generic drugs. CMS names the drug for 165 of them, across 9 drugs with 11 or more claims each, at $605,881 in total drug cost. In 2023, CMS named 119 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Gojo for performance year 2024, reported as part of a group. CMS lists Dr. Gojo as offering telehealth.

Dmand AI links 87 papers to Dr. Gojo, published from 2010 to 2025. 2021 was the busiest year, with 10. The most frequent topics are Leukemia, Myeloid, Acute, Antineoplastic Combined Chemotherapy Protocols and Hematopoietic Stem Cell Transplantation. Dr. Gojo has published most often in J Natl Compr Canc Netw. Dr. Gojo's most frequent co-authors are Amy Elizabeth Dezern, MD, Leonido Luznik, MD and Gabriel Ghiaur, MD.

Dmand AI links Dr. Gojo to 9 clinical trials, 4 of them phase 1 studies. 3 are still active or recruiting. Conditions studied include Leukemia, Myeloid, Acute, Leukemia, Myeloid and Burkitt Lymphoma. National Cancer Institute (NCI) sponsors the most, 5.

CMS Open Payments shows 33 general payments to Dr. Gojo from 11 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 76% of the total. Genentech, Inc. paid the most, $11,206.